Register entry
- Registered sites
- 12
- Active NDC listings
- 3
- Live patents
- 0
- Countries
- 4
- Base
- France
Authorisation
Registered operations
Analytical testing12Active ingredient (API) manufacture7Labelling7Finished drug manufacture7Packaging7Relabelling1Repackaging1sterilize1
Sites
Registered establishments
12| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Sanofi-Aventis Deutschland GmbHRegistrant: Sanofi | Br�ningstr. 50, Frankfurt am Main, 65926, Germany (DEU) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3003195501313218430 |
| Sanofi Winthrop IndustrieRegistrant: Sanofi | 1 RUE DE LA VIERGE, AMBARES ET LAGRAVE, 33560, France (FRA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3002808208763683216 |
| Sanofi Winthrop IndustrieRegistrant: Sanofi | Route D Avignon, Aramon, 30390, France (FRA) | Analytical testing, Active ingredient (API) manufacture | 3002808341280414075 |
| Sanofi Winthrop IndustrieRegistrant: Sanofi | 1051 Boulevard Industriel, Le Trait, 76580, France (FRA) | Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging, sterilize | 3003259844297730488 |
| Sanofi Winthrop IndustrieRegistrant: Sanofi | Zone Industrielle Du Bois Vert Rue Gilles Roberval, Plo�rmel, 56800, France (FRA) | Analytical testing, Active ingredient (API) manufacture | 3005224144280374656 |
| Sanofi Winthrop IndustrieRegistrant: Sanofi | 45 Chemin de Meteline, Sisteron, 04200, France (FRA) | Analytical testing, Active ingredient (API) manufacture | 1000476619280437582 |
| Sanofi Winthrop IndustrieRegistrant: Sanofi | 30 AVENUE GUSTAVE EIFFEL, Tours, Centre 37100, France (FRA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3003282644571879985 |
| Sanofi Winthrop IndustrieRegistrant: Sanofi | 9 Quai Jules Guesde, Vitry sur-Seine, 94400, France (FRA) | Analytical testing, Active ingredient (API) manufacture | 3002808000280366666 |
| Sanofi S.r.l.Registrant: Sanofi | Via Valcanello, 4, Anagni, Frosinone 03012, Italy (ITA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3002807108338454274 |
| Sanofi S.r.l.Registrant: Sanofi | Strada Statale 17 Km 22, Scoppito, 67019, Italy (ITA) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3006947840543209212 |
| Sanofi-Aventis Singapore Pte. Ltd.Registrant: Sanofi | 61 Gul Circle, Singapore, 629585, Singapore (SGP) | Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging | 3003091951659159243 |
| Sanofi-Aventis Singapore Pte. Ltd.Registrant: Sanofi | 5 Tuas Street 2, Singapore, 639328, Singapore (SGP) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3043161415659159250 |
Catalogue
Drug listings by form and route
33 active NDC listings: 3 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 3.
| Dosage form | NDCs |
|---|---|
| injection, powder, lyophilized, for solution | 1 |
| tablet | 1 |
| tablet, film coated | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| sanofi s.r.l. | 3 |
Catalogue
Marketed products
3| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | IMIGLUCERASE | injection, powder, lyophilized, for solution | 12522-7100DRUG FOR FURTHER PROCESSING |
| - | belumosudil | tablet | 12522-3310DRUG FOR FURTHER PROCESSING |
| - | rilzabrutinib | tablet, film coated | 12522-3331DRUG FOR FURTHER PROCESSING |
Neighbours
Registered in the same town
12- Merck & Co., Inc.Singapore, SGP · 5 sites
- Novartis Pharmaceuticals CorporationSingapore, SGP
- Baxalta US Inc.Singapore, SGP
- Charles River Laboratories, Inc.Singapore, SGP
- Lonza Biologics IncSingapore, SGP
- AbbVie Inc.Singapore, SGP
- Pfizer IncSingapore, SGP
- Amgen, IncSingapore, SGP
- Genentech, Inc.Singapore, SGP
- Almac Pharma Services (Ireland) LimitedSingapore, SGP
- EUROAPIFrankfurt am Main, DEU
- Corden Pharma International GmbHFrankfurt am Main, DEU
Compare
Comparable companies in France
- EMD Serono, Inc.12 sites · 18 NDC
- LFB USA Inc.6 sites · 0 NDC
- Boiron Inc.5 sites · 2,088 NDC
- EUROAPI5 sites · 41 NDC
- Sanofi Vaccines US Inc.5 sites · 25 NDC
- PCAS3 sites · 20 NDC
- Pierre Fabre Pharmaceuticals, Inc.3 sites · 13 NDC
- Unither Manufacturing LLC3 sites · 6 NDC
- Boehringer Ingelheim Animal Health USA Inc.3 sites · 0 NDC
- Ethypharm3 sites · 0 NDC
Enquiry
Common questions
- Is Sanofi FDA approved?
- Sanofi holds 12 FDA-registered establishments across 4 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Sanofi's drugs manufactured?
- At registered sites in Germany, France, Italy, Singapore. The FDA register lists Frankfurt am Main; AMBARES ET LAGRAVE; Aramon; Le Trait; Plo�rmel; Sisteron, and 5 more. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, relabelling, repackaging, sterilize.
- What drugs does Sanofi make?
- 3 products are listed under Sanofi in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution; tablet; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.